Hear about our latest news, events and funding opportunities.
Scotland’s investments create a launch-pad for ambitious large-scale programmes in Precision Medicine.
A new collaboration in genomic medicine sees Scotland join AstraZeneca’s global genomics initiative – further demonstrating Scotland’s ability to attract major industry projects.
Read the article in Business Quarter.
This new fund is aimed at life science companies and or consortia with academic partners looking to become part of Scotland's national collaborative programme in Precision Medicine.
Find out how we can help with your Project.
To join us or to help get your collaboration started.
Get in touch with us at SMS-IC to find out more.